A Lyakhovitsky

Summary

Country: Israel

Publications

  1. ncbi Novel mutations in two families with Darier's disease
    B Amichai
    Department of Dermatology, Huzot Clinic of Clalit Health Services, Ashkelon, Israel
    Int J Dermatol 46:64-7. 2007
  2. ncbi Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    Mycopathologia 169:343-9. 2010
  3. ncbi Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Br J Dermatol 162:46-50. 2010
  4. ncbi A rationale for systemic treatment in onychomycosis with negative results on fungal examination
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 36:724-7. 2011
  5. ncbi A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e602-4. 2009
  6. ncbi Cutaneous hyperpigmentation during therapy with hydroxychloroquine
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    J Clin Rheumatol 13:113. 2007
  7. ncbi Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
    A Lyakhovitsky
    Sheba Medical Center Dermatology Department, Tel Hashomer, Ramat Gan, Israel
    J Eur Acad Dermatol Venereol 24:43-9. 2010
  8. ncbi Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dtsch Dermatol Ges 5:1108-11. 2007
  9. ncbi Onychomycosis in psoriatic patients - rationalization of systemic treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Mycoses 53:340-3. 2010
  10. ncbi Onychomycosis: rationalization of topical treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:415-6. 2008

Collaborators

  • A Shemer
  • B Amichai
  • Boaz Amichai
  • M H Grunwald
  • H Trau
  • B Davidovici
  • David Barak
  • B Nitzan
  • Orit Sholto
  • Henri Trau
  • R Mosckovitz
  • Shirly Ben-Yaakov
  • Rachel Mosckovitz
  • Boaz Nitzan
  • Michael Royz
  • L Peleg
  • M Karpati
  • Marcelo H Grunwald
  • Andera Gat
  • B Goldman

Detail Information

Publications13

  1. ncbi Novel mutations in two families with Darier's disease
    B Amichai
    Department of Dermatology, Huzot Clinic of Clalit Health Services, Ashkelon, Israel
    Int J Dermatol 46:64-7. 2007
    ..Deleterious mutations in the gene ATP2A2 which encodes SERCA2, a calcium pump of the sarco/endoplasmic reticulum underlie the disease...
  2. ncbi Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    Mycopathologia 169:343-9. 2010
    ..Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very difficult...
  3. ncbi Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Br J Dermatol 162:46-50. 2010
    ..Conclusions The delivery of terbinafine under an electrical current of 100 microA cm(-2) appears to be efficacious and safe and is well tolerated for the treatment of nail onychomycosis...
  4. ncbi A rationale for systemic treatment in onychomycosis with negative results on fungal examination
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 36:724-7. 2011
    ..Laboratory confirmation of fungal infection is currently accepted as a requirement before initiation of antifungal treatment in clinical practice...
  5. ncbi A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e602-4. 2009
    ..001) in the study group compared with the control group. The liquid soap was found to be effective in patients with AD, as use of this soap in patients with stable mild to moderate AD improved the parameters studied...
  6. ncbi Cutaneous hyperpigmentation during therapy with hydroxychloroquine
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    J Clin Rheumatol 13:113. 2007
  7. ncbi Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
    A Lyakhovitsky
    Sheba Medical Center Dermatology Department, Tel Hashomer, Ramat Gan, Israel
    J Eur Acad Dermatol Venereol 24:43-9. 2010
    ..This study assessed the efficacy and safety of treatment with low weekly doses of methotrexate for moderate-to-severe AD in adults...
  8. ncbi Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dtsch Dermatol Ges 5:1108-11. 2007
    ..The purpose of this study was to compare results of curettage technique of nail sampling in the diagnosis of onychomycosis from three different sites of the affected nail to establish the best location of sampling...
  9. ncbi Onychomycosis in psoriatic patients - rationalization of systemic treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Mycoses 53:340-3. 2010
    ..Considering the low response to onychomycosis systemic therapy in psoriatic patients and the potential side-effects of the treatment, the rationality of this treatment is questionable...
  10. ncbi Onychomycosis: rationalization of topical treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:415-6. 2008
    ..Fungal infection of the nail affects millions of people worldwide and has an estimated prevalence of more than 10% of the general population...
  11. ncbi Comparative study of nail sampling techniques in onychomycosis
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 36:410-4. 2009
    ..With each technique we found that the culture sensitivity improved as the location of the sample was more proximal. More types of pathogens were detected in samples taken by both methods from proximal parts of the affected nails...
  12. ncbi Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 37:137-9. 2010
    ..No adverse effects were noted throughout the treatment period. Ciclopirox nail lacquer seems to be slightly more effective than other topical modalities and could be used in patients who cannot or do not want systemic treatment...
  13. ncbi Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:417-8. 2008
    ..Seborrheic dermatitis is a common chronic disease. Malassezia yeasts have been implicated in the pathogenesis of this disease. Antifungal agents are known to be effective in the treatment of Malassezia yeast infections...